Skip to main content

Pneumology

The group’s basic and clinical research activity, above all, surrounds the fields of inflammation and repair, respiratory insufficiency and tissue hypoxia, and these fields complement one another and are connected through the study of conditions such as asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, infections, transplants, pulmonary hypertension or sleep-related breathing disorders.

The group has an experimental research laboratory and a clinical research and clinical trial unit. It is made up of professionals from different specialties (pulmonologists, biologists, nurses, laboratory technicians, physiotherapists etc.). This multidisciplinary team provides an added value to the group and guarantees the existence of the critical mass necessary to carry out scientific projects.

Our group is a node that belongs to the CIBERES network (CIBER for respiratory diseases) and also works in collaboration with groups of the highest national and international prestige.

Publications

Cluster-derived obstructive sleep apnea phenotypes and outcomes at five year follow-up.

PMID: 34569926
Journal: Journal of Clinical Sleep Medicine
Year: 2022
Reference: J Clin Sleep Med. 2022 Feb 1;18(2):597-607. doi: 10.5664/jcsm.9674.
Impact factor: 4.062
Publication type: Paper in international publication
Authors: Lloberes, Patricia, Ferrer, Jaume, Mota-Foix, Miriam, Sampol, Gabriel, Silveira, Maria Guadalupe et al.
DOI: 10.5664/jcsm.9674

Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function.

PMID: 35083324
Journal: ERJ open research
Year: 2022
Reference: ERJ Open Res. 2022 Jan 24;8(1). pii: 00375-2021. doi: 10.1183/23120541.00375-2021. eCollection 2022 Jan.
Impact factor: 0
Publication type: Paper in international publication
Authors: Valenzuela, Claudia, Ussetti, Piedad, Laporta, Rosalia, Rodriguez-Portal, Jose A, van Moorsel, Coline H M, van der Vis, Joanne J, Quanjel, Marian J R, Tena-Garitaonaindia, Mireia, Sanchez de Medina, Fermin, Mateo, Francesca et al.
DOI: 10.1183/23120541.00375-2021

Characterisation of Eosinophilic Bronchiectasis: A European Multicohort Study.

PMID: 35050830
Journal: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Year: 2022
Reference: Am J Respir Crit Care Med. 2022 Apr 15;205(8):894-902. doi: 10.1164/rccm.202108-1889OC.
Impact factor: 21.405
Publication type: Paper in international publication
Authors: Keir, Holly R, Loebinger, Michael R, Blasi, Francesco, Welte, Tobias, Sibila, Oriol, Aliberti, Stefano, Chalmers, James D, Altenburg, Josje, Polverino, Eva, Cant, Erin et al.
DOI: 10.1164/rccm.202108-1889OC

A new tool to screen patients with severe obstructive sleep apnea in the primary care setting: a prospective multicenter study.

PMID: 35033055
Journal: BMC Pulmonary Medicine
Year: 2022
Reference: BMC Pulm Med. 2022 Jan 15;22(1):38. doi: 10.1186/s12890-022-01827-0.
Impact factor: 3.317
Publication type: Paper in international publication
Authors: Farga Martinez, M feminine Del Mar, Reverte Simo, Montserrat, Argemi Saburit, Nuria, Medrano Medrano, Casimira, Puig Garcia, Marineus, Santos Santos, M feminineAngeles, Valverde Trillo, Pepi, Mayos, Merce, Penacoba, Patricia, Llauger, Maria Antonia et al.
DOI: 10.1186/s12890-022-01827-0

Treatment Pathways Before and After Triple Therapy in COPD: A Population-based Study in Primary Care in Spain.

PMID: 33004238
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2021
Reference: Arch Bronconeumol. 2021 Mar;57(3):205-213. doi: 10.1016/j.arbres.2020.07.032. Epub 2020 Sep 29.
Impact factor: 4.872
Publication type: Paper in national publication
Authors: Monteagudo, Monica, Nunez, Alexa, Solntseva, Iryna, Dhalwani, Nafeesa, Booth, Alison, Barrecheguren, Miriam, Lambrelli, Dimitra, Miravitlles, Marc et al.
DOI: 10.1016/j.arbres.2020.07.032

Portopulmonary hypertension: prognosis and management in the current treatment era. Results from the REHAP Registry.

PMID: 31943676
Journal: INTERNAL MEDICINE JOURNAL
Year: 2021
Reference: Intern Med J. 2021 Mar;51(3):355-365. doi: 10.1111/imj.14751.
Impact factor: 2.048
Publication type: Paper in international publication
Authors: Alvarez Vega, P, Barbera, J A, Barrios Garrido-Lestache, E, Bedate, P, Blanco, I, Cadenas, S, Cifrian, J M, Del Cerro, M J, Domingo, J A, Dos, L et al.
DOI: 10.1111/imj.14751

Nebulized micafungin treatment for Scopulariopsis/Microascus tracheobronchitis in lung transplant recipients.

PMID: 33722884
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2021
Reference: Antimicrob Agents Chemother. 2021 May 18;65(6). pii: AAC.02174-20. doi: 10.1128/AAC.02174-20. Print 2021 May 18.
Impact factor: 5.191
Publication type: Paper in international publication
Authors: Los-Arcos, Ibai, Berastegui, Cristina, Martin-Gomez, Maria Teresa, Grau, Santiago, Campany-Herrero, David, Deu, Maria, Sacanell, Judith, Campillo, Nuria, Bravo, Carles, Len, Oscar et al.
DOI: 10.1128/AAC.02174-20

Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial.

PMID: 33357499
Journal: Lancet Respiratory Medicine
Year: 2021
Reference: Lancet Respir Med. 2021 Mar;9(3):260-274. doi: 10.1016/S2213-2600(20)30414-8. Epub 2020 Dec 22.
Impact factor: 30.7
Publication type: Paper in international publication
Authors: Beghe, Bianca, Harrison, Tim W, Chanez, Pascal, Menzella, Francesco, Canonica, Giorgio Walter, Louis, Renaud, Cosio, Borja G, Lugogo, Njira L, Mohan, Arjun, Burden, Annie et al.
DOI: 10.1016/S2213-2600(20)30414-8

Cluster Analysis to Identify Apnea-Hypopnea Syndrome Phenotypes: Where Are We Heading?

PMID: 31902627
Journal: ARCHIVOS DE BRONCONEUMOLOGIA
Year: 2020
Reference: Arch Bronconeumol. 2020 Nov;56(11):689-690. doi: 10.1016/j.arbres.2019.11.023. Epub 2020 Jan 3.
Impact factor: 4.957
Publication type: Editorial in national publication
Authors: Silveira, Maria Guadalupe, Lloberes, Patricia et al.
DOI: 10.1016/j.arbres.2019.11.023

RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371384
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702053. doi: 10.1183/13993003.02053-2017. Print 2018 Jan.
Impact factor: 12.242
Publication type: Paper in international publication
Authors: Aksamit, Timothy, De Soyza, Anthony, Bandel, Tiemo-Joerg, Criollo, Margarita, Elborn, J Stuart, Operschall, Elisabeth, Polverino, Eva, Roth, Katrin, Winthrop, Kevin L, Wilson, Robert et al.
DOI: 10.1183/13993003.02053-2017

RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis.

PMID: 29371383
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 25;51(1). pii: 51/1/1702052. doi: 10.1183/13993003.02052-2017. Print 2018 Jan.
Impact factor: 12.242
Publication type: Paper in international publication
Authors: Wilson, Robert, Winthrop, Kevin L, Polverino, Eva, De Soyza, Anthony, Aksamit, Timothy, Bandel, Tiemo-Joerg, Criollo, Margarita, Elborn, J Stuart, Operschall, Elisabeth, Roth, Katrin et al.
DOI: 10.1183/13993003.02052-2017

Characterisation of the "Frequent Exacerbator Phenotype" in Bronchiectasis.

PMID: 29357265
Journal: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
Year: 2018
Reference: Am J Respir Crit Care Med. 2018 Jun 1;197(11):1410-1420. doi: 10.1164/rccm.201711-2202OC.
Impact factor: 15.239
Publication type: Paper in international publication
Authors: Rutherford, Robert M, Chalmers, James D, Aliberti, Stefano, Filonenko, Anna, Shteinberg, Michal, Goeminne, Pieter C, Hill, Adam T, Fardon, Thomas C, Obradovic, Dusanka, Gerlinger, Christoph et al.
DOI: 10.1164/rccm.201711-2202OC

Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial.

PMID: 29326318
Journal: EUROPEAN RESPIRATORY JOURNAL
Year: 2018
Reference: Eur Respir J. 2018 Jan 11;51(1). pii: 51/1/1701926. doi: 10.1183/13993003.01926-2017. Print 2018 Jan.
Impact factor: 12.242
Publication type: Paper in international publication
Authors: Munoz, Gerard, de Gracia, Javier, Buxo, Maria, Alvarez, Antonio, Vendrell, Montserrat et al.
DOI: 10.1183/13993003.01926-2017

Occupational lung diseases: from old and novel exposures to effective preventive strategies.

PMID: 28089118
Journal: Lancet Respiratory Medicine
Year: 2017
Reference: Lancet Respir Med. 2017 May;5(5):445-455. doi: 10.1016/S2213-2600(16)30424-6. Epub 2017 Jan 7.
Impact factor: 19.287
Publication type: Review in national publication
Authors: Cullinan, Paul, Munoz, Xavier, Suojalehto, Hille, Agius, Raymond, Jindal, Surinder, Sigsgaard, Torben, Blomberg, Anders, Charpin, Denis, Annesi-Maesano, Isabella, Gulati, Mridu et al.
DOI: 10.1016/S2213-2600(16)30424-6

Effect of adjunctive perampanel on the quality of sleep and daytime somnolence in patients with epilepsy.

PMID: 28066710
Journal: Epilepsy & behavior case reports
Year: 2017
Reference: Epilepsy Behav Case Rep. 2016 Oct 21;7:13-15. doi: 10.1016/j.ebcr.2016.10.002. eCollection 2017.
Impact factor: 0
Publication type: Paper in international publication
Authors: Salas-Puig, Xavier, Ferrer, Alex, Jurado, Maria Jose, Gonzalez-Cuevas, Montserrat, Romero, Odile, Toledo, Manuel, Quintana, Manuel, Cambrodi, Roser, Santamarina, Estevo et al.
DOI: 10.1016/j.ebcr.2016.10.002

Blog

News

The EXPOSIM project will investigate the impact of environmental stressors such as pollution, noise and aeroallergens on immune-mediated diseases.

This recognition highlights both his career and the level of respiratory research in Spain.

The ERS Awards recognize outstanding members for their exceptional contributions in the field of respiratory medicine.

EXIMIOUS

EXIMIOUS (Mapping Exposure-Induced Immune Effects: Connecting the Exposome and the Immunome), un projecte finançat per la Unió Europea que engloba 15 organitzacions de 7 països europeus.

EXIMIOUS té com a objectiu estudiar l’exposoma, és a dir, l’exposició a factors ambientals al llarg de la vida, per entendre la seva relació amb les malalties immunomediades, com ara les malalties autoimmunes o les al·lèrgies. Des del VHIR està liderat per la Dra. M Jesús Cruz i el seu equip de Pneumologia.